Treatment patterns among mixed phenotype transthyretin amyloidosis patients: A real-world multinational survey
We Recommend
Disclosures
<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Industry Salary/Salary Support/Employee (full time or part time) - AstraZenca</li><li>Equity/Stock(s)/Options - AstraZenca</li></ul>